Nasal spray targeting immune cells reversed long COVID brain fog in mice
This week brought fresh insights into long COVID's grip on the brainβand some surprisingly promising treatment approaches. From nasal sprays that reversed cognitive problems in mice to blood tests that could predict who's at risk, researchers are getting closer to understanding why some people can't shake COVID's effects.
π§ Nasal Anti-CD3 Spray Reverses Long COVID Brain Fog in Mice
Mice given a nasal spray containing anti-CD3 antibodies showed restored memory and reduced brain inflammation after mild SARS-CoV-2 infection
The treatment increased regulatory T cells in the brain by boosting FoxP3+ IL-10+ populations, which help control inflammation
Brain scans revealed the spray reduced harmful microglial activation (brain immune cells gone rogue) and restored neurogenesis (new brain cell growth) in the hippocampus
Why it matters: This suggests long COVID brain fog might be treatable with targeted immune therapies delivered through the noseβa non-invasive approach that could bypass the blood-brain barrier.
Key Findings
π― Stellate Ganglion Block Shows Promise for Multiple Long COVID Symptoms
Seven studies found that stellate ganglion block (a nerve injection procedure) helped 55.8% to 100% of long COVID patients across different symptoms
The strongest improvements (over 80% of patients reporting relief) were seen in cough, shortness of breath, headache, joint pain, and pins-and-needles sensations
All studies lacked control groups and had small sample sizes, limiting the strength of evidence
π Blood Markers Predict Long COVID Risk from Day One
Researchers analyzed 300 people 10 months after mild COVID-19 and found 59% had long COVID symptoms
Higher SARS-CoV-2 viral loads during acute infection (CT values β€20) were linked to neuropsychiatric and muscle-related long COVID symptoms
Blood tests showed elevated inflammatory markers (IL-6, ferritin) and vitamin D deficiency were associated with specific symptom clusters
π¬ Brain Scans Reveal Widespread Inflammation in Older Adults with Long COVID
PET brain scans of older adults with long COVID showed significantly higher inflammation markers throughout the brain compared to healthy controls
The inflammation was detected in prefrontal, temporal, parietal, and occipital regions, plus the hippocampus, thalamus, and cerebellum
Long COVID patients also scored higher on depression and fatigue measures compared to healthy older adults
π€ Poor Sleep Quality Predicts Long COVID Persistence
A one-year study of 957 people with long COVID found that non-restorative sleep increased the risk of persistent symptoms by 33%
Surprisingly, other sleep problems like difficulty falling asleep or staying asleep didn't predict long COVID persistence
Non-restorative sleep appeared to work through different mechanisms than typical sleep disturbances
𧬠Protein Signatures Persist 3 Months After COVID Regardless of Symptoms
Blood protein analysis revealed distinct patterns in all previously infected individuals compared to never-infected controls, regardless of whether they had long COVID
People with long COVID showed elevated levels of six specific proteins linked to inflammation, blood clotting, and metabolism (PCSK9, CST3, C1Q, CPB2, KNG1, GAPDH)
Oxidative stress markers and DNA damage were significantly higher in long COVID patients compared to recovered individuals
π₯ Pre-Pandemic Health Strongly Predicted Long COVID Risk
Analysis of 12,033 UK adults found that pre-pandemic psychological distress increased disabling long COVID risk by 44%
Poor sleep quality before the pandemic nearly doubled the risk (fairly bad sleep: 92% increase, very bad sleep: 96% increase)
Women, middle-aged adults (30-69), and those with existing health conditions were at significantly higher risk
Implications
This week's research reveals long COVID as a complex condition involving persistent inflammation, immune dysfunction, and metabolic changes that can be detected months after infection. The promising mouse study with nasal anti-CD3 therapy, combined with growing evidence that pre-pandemic health predicts outcomes, suggests both treatment possibilities and prevention strategies may be on the horizon.
Studies in this issue
Primary sources used for this newsletter.
- Nasal Anti-CD3 Antibody Treatment May Reduce Brain Inflammation and Improve Memory and New Brain Cell Growth After COVID in Micemain storybioRxiv : the preprint server for biology2026-04-17PMID 41993482
- Nonrestorative sleep linked to ongoing long-term symptoms after COVID-19 recoverykey findingSleep and biological rhythms2026-04-13PMID 41969992
- Unique blood protein patterns 3 months after COVID-19 infection, regardless of ongoing symptomskey findingScientific reports2026-04-17PMID 41998026
- High COVID-19 virus levels and body inflammation linked to brain-related and muscle symptoms in long COVIDkey findingPloS one2026-04-15PMID 41984770
- Early Risk Factors for Long COVID That Causes Disabilitykey findingJournal of tropical medicine2026-04-13PMID 41971233
- Nerve Block Treatment for Long COVID Symptoms: A Systematic Reviewkey findingCurrent pain and headache reports2026-04-13PMID 41973314
- Brain and mental symptoms of Long COVID in older adults and possible links to brain inflammation: Early findings from a small groupkey findingJournal of the neurological sciences2026-04-15PMID 41985377
Continue reading
All Long Covid issuesGet the next Long Covid issue
Seven papers, once a week. Free.